@inproceedings{inproceedings, title  = {{A second autologous stem cell transplant induces superior response durability following bortezomib-containing re-induction therapy for relapsed multiple myeloma: results from the BSBMT/UKMF myeloma x (intensive) trial}},

 url = {{}},

 year = {{2013}},

 month = {{4}},

 author = {{Cook G and Williams C and Szubert A and Yong K and Cavet J and Hunter H and Bird J and Bell S and O'Connor S and Cavenagh J and Snowden J et al}},

 volume = {{48}},

 journal = {{BONE MARROW TRANSPLANTATION}},

 pages = {{S17-S17}},

 note = {{Accessed on 2024/12/26}}}